We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draws Up Blueprint for Pre-Approval Facility Reviews
FDA Draws Up Blueprint for Pre-Approval Facility Reviews
The FDA has outlined plans for coordination between CDER and ORA in checking out the manufacturing facilities of drugmakers seeking approval for new pharmaceuticals.